Lilly To Inject $1B In New Manufacturing Facility In North Carolina, US


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Eli Lilly And Co (NYSE:LLYplans to invest over $1 billion to create a new manufacturing site in the U.S, with nearly 600 new jobs in Concord, North Carolina. 

  • The new facility will manufacture parenteral (injectable) products and devices and increase the company's manufacturing capacity. 
  • In 2020, Lilly announced a $470 million investment in North Carolina's Research Triangle Park. 
  • In addition, an estimated 500 additional positions will be required while the facility is under construction.
  • Over the last five years, Lilly has invested over $4 billion in global manufacturing, including more than $2 billion in the U.S. 
  • The company announced plans to invest $500 million in a new biopharmaceutical manufacturing facility in Limerick, Ireland
  • Lilly anticipates additional future investments in manufacturing to address growth expected from potential new medicines to treat diabetes, Alzheimer's disease, cancer, and autoimmune conditions.
  • Price Action: LLY shares up 1.86% at $241.13 during the market session on the last check Friday.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsHealth CareGeneralBriefs